Diabetes, Vol 48, Issue 3 491-498, Copyright © 1999 by American Diabetes Association

ARTICLES

The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles

J Janson, RH Ashley, D Harrison, S McIntyre and PC Butler
Department of Medical Sciences, University of Edinburgh, Scotland, UK.

NIDDM is characterized by islet amyloid deposits and decreased beta-cell mass. Islet amyloid is derived from the locally expressed protein islet amyloid polypeptide (IAPP). While it is now widely accepted that abnormal aggregation of IAPP has a role in beta-cell death in NIDDM, the mechanism remains unknown. We hypothesized that small IAPP aggregates, rather than mature large amyloid deposits, are cytotoxic. Consistent with this hypothesis, freshly dissolved human (h)-IAPP was cytotoxic when added to dispersed mouse and human islet cells, provoking the formation of abnormal vesicle-like membrane structures in association with vacuolization and cell death. Human islet cell death occurred by both apoptosis and necrosis, predominantly between 24 and 48 h after exposure to h-IAPP. In contrast, the addition to dispersed islet cells of matured h-IAPP containing large amyloid deposits of organized fibrils was seldom associated with vesicle-like structures or features of cell death, even though the cells were often encased in the larger amyloid deposits. Based on these observations, we hypothesized that h-IAPP cytotoxicity is mediated by membrane damage induced by early h-IAPP aggregates. Consistent with this hypothesis, application of freshly dissolved h-IAPP to voltage-clamped planar bilayer membranes (a cell-free in vitro system) also caused membrane instability manifested as a marked increase in conductance, increased membrane electrical noise, and accelerated membrane breakage, effects that were absent using matured h-IAPP or rat IAPP solutions. Light-scattering techniques showed that membrane toxicity corresponded to h-IAPP aggregates containing approximately 25-6,000 IAPP molecules, an intermediate-sized amyloid particle that we term intermediate-sized toxic amyloid particles (ISTAPs). We conclude that freshly dissolved h-IAPP is cytotoxic and that this cytotoxicity is mediated through an interaction of ISTAPs with cellular membranes. Once ISTAPs mature into amyloid deposits comprising >10(6) molecules, the capacity of h-IAPP to cause membrane instability and islet cell death is significantly reduced or abolished. These data may have implications for the mechanism of cell death in other diseases characterized by local amyloid formation (such as Alzheimer's disease).
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. Bonner-Weir and T. D. O'Brien Islets in Type 2 Diabetes: In Honor of Dr. Robert C. Turner Diabetes, November 1, 2008; 57(11): 2899 - 2904. [Full Text] [PDF]

				L. Marzban, A. Tomas, T. C. Becker, L. Rosenberg, J. Oberholzer, P. E. Fraser, P. A. Halban, and C. B. Verchere Small Interfering RNA-Mediated Suppression of Proislet Amyloid Polypeptide Expression Inhibits Islet Amyloid Formation and Enhances Survival of Human Islets in Culture Diabetes, November 1, 2008; 57(11): 3045 - 3055. [Abstract] [Full Text] [PDF]

				S. Zhang, H. Liu, H. Yu, and G. J.S. Cooper Fas-Associated Death Receptor Signaling Evoked by Human Amylin in Islet {beta}-Cells Diabetes, February 1, 2008; 57(2): 348 - 356. [Abstract] [Full Text] [PDF]

				S.-H. Shim, D. B. Strasfeld, Y. L. Ling, and M. T. Zanni Multidimensional Ultrafast Spectroscopy Special Feature: Automated 2D IR spectroscopy using a mid-IR pulse shaper and application of this technology to the human islet amyloid polypeptide PNAS, September 4, 2007; 104(36): 14197 - 14202. [Abstract] [Full Text] [PDF]

				S. Casas, R. Gomis, F. M. Gribble, J. Altirriba, S. Knuutila, and A. Novials Impairment of the Ubiquitin-Proteasome Pathway Is a Downstream Endoplasmic Reticulum Stress Response Induced by Extracellular Human Islet Amyloid Polypeptide and Contributes to Pancreatic {beta}-Cell Apoptosis Diabetes, September 1, 2007; 56(9): 2284 - 2294. [Abstract] [Full Text] [PDF]

				C.-j. Huang, C.-y. Lin, L. Haataja, T. Gurlo, A. E. Butler, R. A. Rizza, and P. C. Butler High Expression Rates of Human Islet Amyloid Polypeptide Induce Endoplasmic Reticulum Stress Mediated {beta}-Cell Apoptosis, a Characteristic of Humans With Type 2 but Not Type 1 Diabetes Diabetes, August 1, 2007; 56(8): 2016 - 2027. [Abstract] [Full Text] [PDF]

				C.-Y. Lin, T. Gurlo, R. Kayed, A. E. Butler, L. Haataja, C. G. Glabe, and P. C. Butler Toxic Human Islet Amyloid Polypeptide (h-IAPP) Oligomers Are Intracellular, and Vaccination to Induce Anti-Toxic Oligomer Antibodies Does Not Prevent h-IAPP-Induced {beta}-Cell Apoptosis in h-IAPP Transgenic Mice Diabetes, May 1, 2007; 56(5): 1324 - 1332. [Abstract] [Full Text] [PDF]

				B. L. Wajchenberg {beta}-Cell Failure in Diabetes and Preservation by Clinical Treatment Endocr. Rev., April 1, 2007; 28(2): 187 - 218. [Abstract] [Full Text] [PDF]

				S. Kim, I. Millet, H. S. Kim, J. Y. Kim, M. S. Han, M.-K. Lee, K.-W. Kim, R. S. Sherwin, M. Karin, and M.-S. Lee NF-{kappa}B prevents beta cell death and autoimmune diabetes in NOD mice PNAS, February 6, 2007; 104(6): 1913 - 1918. [Abstract] [Full Text] [PDF]

				S. Zraika, R. L. Hull, J. Udayasankar, A. Clark, K. M. Utzschneider, J. Tong, F. Gerchman, and S. E. Kahn Identification of the Amyloid-Degrading Enzyme Neprilysin in Mouse Islets and Potential Role in Islet Amyloidogenesis Diabetes, February 1, 2007; 56(2): 304 - 310. [Abstract] [Full Text] [PDF]

				R. A. Ritzel, J. J. Meier, C.-Y. Lin, J. D. Veldhuis, and P. C. Butler Human Islet Amyloid Polypeptide Oligomers Disrupt Cell Coupling, Induce Apoptosis, and Impair Insulin Secretion in Isolated Human Islets Diabetes, January 1, 2007; 56(1): 65 - 71. [Abstract] [Full Text] [PDF]

				J. J. Meier, R. Kayed, C.-Y. Lin, T. Gurlo, L. Haataja, S. Jayasinghe, R. Langen, C. G. Glabe, and P. C. Butler Inhibition of human IAPP fibril formation does not prevent beta-cell death: evidence for distinct actions of oligomers and fibrils of human IAPP Am J Physiol Endocrinol Metab, December 1, 2006; 291(6): E1317 - E1324. [Abstract] [Full Text] [PDF]

				L. Marzban, C. J. Rhodes, D. F. Steiner, L. Haataja, P. A. Halban, and C. B. Verchere Impaired NH2-Terminal Processing of Human Proislet Amyloid Polypeptide by the Prohormone Convertase PC2 Leads to Amyloid Formation and Cell Death. Diabetes, August 1, 2006; 55(8): 2192 - 2201. [Abstract] [Full Text] [PDF]

				C. G. Glabe and R. Kayed Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis Neurology, January 24, 2006; 66(1_suppl_1): S74 - S78. [Abstract] [Full Text] [PDF]

				C.-Y. Lin, T. Gurlo, L. Haataja, W. A. Hsueh, and P. C. Butler Activation of Peroxisome Proliferator-Activated Receptor-{gamma} by Rosiglitazone Protects Human Islet Cells against Human Islet Amyloid Polypeptide Toxicity by a Phosphatidylinositol 3'-Kinase-Dependent Pathway J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6678 - 6686. [Abstract] [Full Text] [PDF]

				J. Yang, C. E. Robert, B. R. Burkhardt, R. A. Young, J. Wu, Z. Gao, and B. A. Wolf Mechanisms of Glucose-Induced Secretion of Pancreatic-Derived Factor (PANDER or FAM3B) in Pancreatic {beta}-Cells Diabetes, November 1, 2005; 54(11): 3217 - 3228. [Abstract] [Full Text] [PDF]

				Z. Medarova, S. Bonner-Weir, M. Lipes, and A. Moore Imaging {beta}-Cell Death With a Near-Infrared Probe Diabetes, June 1, 2005; 54(6): 1780 - 1788. [Abstract] [Full Text] [PDF]

				D. H. J. Lopes, C. Colin, T. L. Degaki, A. C. V. de Sousa, M. N. N. Vieira, A. Sebollela, A. M. B. Martinez, C. Bloch Jr., S. T. Ferreira, and M. C. Sogayar Amyloidogenicity and Cytotoxicity of Recombinant Mature Human Islet Amyloid Polypeptide (rhIAPP) J. Biol. Chem., October 8, 2004; 279(41): 42803 - 42810. [Abstract] [Full Text] [PDF]

				R. L. Hull, G. T. Westermark, P. Westermark, and S. E. Kahn Islet Amyloid: A Critical Entity in the Pathogenesis of Type 2 Diabetes J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3629 - 3643. [Abstract] [Full Text] [PDF]

				A. E. Butler, J. Jang, T. Gurlo, M. D. Carty, W. C. Soeller, and P. C. Butler Diabetes Due to a Progressive Defect in {beta}-Cell Mass in Rats Transgenic for Human Islet Amyloid Polypeptide (HIP Rat): A New Model for Type 2 Diabetes Diabetes, June 1, 2004; 53(6): 1509 - 1516. [Abstract] [Full Text] [PDF]

				J. D. Green, C. Goldsbury, J. Kistler, G. J. S. Cooper, and U. Aebi Human Amylin Oligomer Growth and Fibril Elongation Define Two Distinct Phases in Amyloid Formation J. Biol. Chem., March 26, 2004; 279(13): 12206 - 12212. [Abstract] [Full Text] [PDF]

				S. Andrikopoulos, R. L. Hull, C. B. Verchere, F. Wang, S. M. Wilbur, T. N. Wight, L. Marzban, and S. E. Kahn Extended life span is associated with insulin resistance in a transgenic mouse model of insulinoma secreting human islet amyloid polypeptide Am J Physiol Endocrinol Metab, March 1, 2004; 286(3): E418 - E424. [Abstract] [Full Text]

				J. Janson, T. Laedtke, J. E. Parisi, P. O'Brien, R. C. Petersen, and P. C. Butler Increased Risk of Type 2 Diabetes in Alzheimer Disease Diabetes, February 1, 2004; 53(2): 474 - 481. [Abstract] [Full Text]

				S. Zhang, J. Liu, M. Dragunow, and G. J. S. Cooper Fibrillogenic Amylin Evokes Islet {beta}-Cell Apoptosis through Linked Activation of a Caspase Cascade and JNK1 J. Biol. Chem., December 26, 2003; 278(52): 52810 - 52819. [Abstract] [Full Text] [PDF]

				H.-L. Zhao, F. M.M. Lai, P. C.Y. Tong, D.-R. Zhong, D. Yang, B. Tomlinson, and J. C.N. Chan Prevalence and Clinicopathological Characteristics of Islet Amyloid in Chinese Patients With Type 2 Diabetes Diabetes, November 1, 2003; 52(11): 2759 - 2766. [Abstract] [Full Text] [PDF]

				A. E. Butler, J. Janson, W. C. Soeller, and P. C. Butler Increased {beta}-Cell Apoptosis Prevents Adaptive Increase in {beta}-Cell Mass in Mouse Model of Type 2 Diabetes: Evidence for Role of Islet Amyloid Formation Rather Than Direct Action of Amyloid Diabetes, September 1, 2003; 52(9): 2304 - 2314. [Abstract] [Full Text] [PDF]

				R. G. Bennett, F. G. Hamel, and W. C. Duckworth An Insulin-Degrading Enzyme Inhibitor Decreases Amylin Degradation, Increases Amylin-Induced Cytotoxicity, and Increases Amyloid Formation in Insulinoma Cell Cultures Diabetes, September 1, 2003; 52(9): 2315 - 2320. [Abstract] [Full Text] [PDF]

				R. A. Ritzel and P. C. Butler Replication Increases {beta}-Cell Vulnerability to Human Islet Amyloid Polypeptide-Induced Apoptosis Diabetes, July 1, 2003; 52(7): 1701 - 1708. [Abstract] [Full Text] [PDF]

				R. L. Hull, S. Andrikopoulos, C. B. Verchere, J. Vidal, F. Wang, M. Cnop, R. L. Prigeon, and S. E. Kahn Increased Dietary Fat Promotes Islet Amyloid Formation and {beta}-Cell Secretory Dysfunction in a Transgenic Mouse Model of Islet Amyloid Diabetes, February 1, 2003; 52(2): 372 - 379. [Abstract] [Full Text] [PDF]

				A. E. Butler, J. Janson, S. Bonner-Weir, R. Ritzel, R. A. Rizza, and P. C. Butler {beta}-Cell Deficit and Increased {beta}-Cell Apoptosis in Humans With Type 2 Diabetes Diabetes, January 1, 2003; 52(1): 102 - 110. [Abstract] [Full Text] [PDF]

				J. E. Gerich Is Reduced First-Phase Insulin Release the Earliest Detectable Abnormality in Individuals Destined to Develop Type 2 Diabetes? Diabetes, February 1, 2002; 51(90001): S117 - 121. [Abstract] [Full Text] [PDF]

				R. N. Bergman, M. Ader, K. Huecking, and G. Van Citters Accurate Assessment of {beta}-Cell Function: The Hyperbolic Correction Diabetes, February 1, 2002; 51(90001): S212 - 220. [Abstract] [Full Text] [PDF]

				F. Wang, R. L. Hull, J. Vidal, M. Cnop, and S. E. Kahn Islet Amyloid Develops Diffusely Throughout the Pancreas Before Becoming Severe and Replacing Endocrine Cells Diabetes, November 1, 2001; 50(11): 2514 - 2520. [Abstract] [Full Text] [PDF]

				S. E. Kahn The Importance of {beta}-Cell Failure in the Development and Progression of Type 2 Diabetes J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4047 - 4058. [Full Text] [PDF]

				J. W.M. Hoppener, B. Ahren, and C. J.M. Lips Islet Amyloid and Type 2 Diabetes Mellitus N. Engl. J. Med., August 10, 2000; 343(6): 411 - 419. [Full Text] [PDF]

				R. BHATIA, H. LIN, and R. LAL Fresh and globular amyloid {beta} protein (1-42) induces rapid cellular degeneration: evidence for A{beta}P channel-mediated cellular toxicity FASEB J, June 1, 2000; 14(9): 1233 - 1243. [Abstract] [Full Text]